Are chilblains a skin expression of COVID-19 microangiopathy?

J Thromb Haemost. 2020 Sep;18(9):2414-2415. doi: 10.1111/jth.15008.

Authors

Marie Baeck¹, Anne Herman¹, Caroline Peeters¹, Liliane Marot^{1

2}, Cedric Hermans³

Affiliations

¹ Division of Dermatology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
² Division of Anatomopathology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
³ Division of Hematology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

No abstract available

Keywords: COVID-19; chilblains; histopathological findings; hypercoagulable state; microthrombosis; thrombotic vasculopathy.

Publication types

Letter

MeSH terms

Biopsy
COVID-19 / blood*
COVID-19 / complications*
Chilblains / blood*
Chilblains / complications*
Disease Outbreaks
Fluorescent Antibody Technique
Humans
Immunoglobulin A / immunology
Immunoglobulin M / immunology
Inflammation
Skin / pathology
Vascular Diseases / blood*
Vascular Diseases / complications*

Substances

Immunoglobulin A
Immunoglobulin M